KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Merck (MRK) EBIT Margin (2016 - 2025)

Merck (MRK) has disclosed EBIT Margin for 17 consecutive years, with 12.99% as the latest value for Q4 2025.

  • On a quarterly basis, EBIT Margin fell 1518.0% to 12.99% in Q4 2025 year-over-year; TTM through Dec 2025 was 7.21%, a 18.0% decrease, with the full-year FY2025 number at 7.21%, down 19.0% from a year prior.
  • EBIT Margin was 12.99% for Q4 2025 at Merck, down from 16.73% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 16.73% in Q3 2025 to a low of 62.25% in Q2 2023.
  • A 5-year average of 2.21% and a median of 0.16% in 2024 define the central range for EBIT Margin.
  • Peak YoY movement for EBIT Margin: soared 19219bps in 2021, then plummeted -6411bps in 2023.
  • Merck's EBIT Margin stood at 0.26% in 2021, then plummeted by -1128bps to 2.66% in 2022, then tumbled by -1431bps to 40.73% in 2023, then skyrocketed by 105bps to 2.19% in 2024, then tumbled by -694bps to 12.99% in 2025.
  • Per Business Quant, the three most recent readings for MRK's EBIT Margin are 12.99% (Q4 2025), 16.73% (Q3 2025), and 9.12% (Q2 2025).